Research

Chrysalis Pharma works with the world's best teams both in chemistry in basic research.

 

Chrysalis -Pharma is developing a portfolio of targeted products for rare diseases, with little or no treatments available for patients.

 

His first and main line of development is serious lung diseases (respiratory system) with a focus on :

 

- Idiopathic Pulmonary Fibrosis

 

- Cystic Fibrosis